Pfizer Under Pressure on Bextra; State Probes
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
162699
Pfizer Inc. on Friday said two small clinical trials showed heart bypass surgery patients taking Bextra, an anti-inflammatory in the same class as the recently withdrawn
507272
Pfizer Inc. said Friday that it will provide health-care professionals with additional information about its Bextra arthritis drug and that it will conduct further studies to confirm the drug&#39;s long-term cardiovascular safety record.
641280
The Food and Drug Administration should immediately yank Celebrex and Bextra from the market to protect Americans from the drugs' heart risks, according to a petition filed with the agency yesterday by Public Citizen. The petition also requests that the FDA freeze applications for Arcoxia and Prexige -- two painkillers under development -- for the same reason.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
84533
Pfizer Inc. PFE.N on Friday said two  clinical trials showed patients taking its anti-inflammatory  drug Bextra had a higher risk of cardiovascular events during  high-risk coronary bypass surgery.
190069
The FDA issues a health advisory for a top Pfizer drug.
697008
WASHINGTON Dec 9, 2004 - The government is warning of potential heart problems associated with the use of the painkiller Bextra in people who have recently had heart bypass surgery.
238078
Pfizer Inc.'s painkiller Bextra will come with a new warning about the possibility of heart attacks and blood clots in patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
557597
Oct. 15, 2004 -- Bextra -- one of two US approved Vioxx sister drugs -- may cause rare skin and heart side effects, its manufacturer today warned doctors.
513204
The Food and Drug Administration is strengthening warnings about the possible risks of a popular arthritis drug. Bextra, which is made by Pfizer Inc.
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
296681
Two small clinical trials showed heart bypass surgery patients taking Bextra, an anti-inflammatory in the same class as the recently withdrawn drug Vioxx, had an increased risk of stroke and heart attack.
586119
The FDA has just changed the warning label on the pain reliever Bextra to emphasize the risk of a rare but potentially fatal &quot;skin reaction,&quot; Stevens-Johnson syndrome.
260806
An Oregon man stopped taking the painkiller Vioxx when it was pulled from the market, switching to Bextra. Then questions were raised this week about Bextra -- and four other